Ingalls & Snyder »

Charles River Laboratories shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2023-12-31 $204k 865 235.84

More positions owned by Ingalls & Snyder

Corcept Therapeutics Incorporated (CORT)
Pioneer Natural Resources (PXD)
Canadian Nat Res Call Call Option (CNQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Williams Companies (WMB)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Roper Industries (ROP)
Hexcel Corporation (HXL)
Stratus Pptys Com New (STRS)
Merck & Co (MRK)
Home Depot (HD)

View all positions for Ingalls & Snyder

Top funds holding Charles River Laboratories

Vanguard Group
ClearBridge Advisors
T. Rowe Price Associates
Meritage Group
Allspring Global Investments Holdings
Southpoint Capital Advisors
Mackenzie Financial
Earnest Partners
Franklin Resources
Bank of America Corporation
Wells Fargo & Company
Charles Schwab Investment Management
Montrusco Bolton Investment
Dimensional Fund Advisors
Victory Capital Management

View all funds holding Charles River Laboratories